Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 27

1.

Recombinant Sendai virus as a novel vaccine candidate for respiratory syncytial virus.

Takimoto T, Hurwitz JL, Zhan X, Krishnamurthy S, Prouser C, Brown B, Coleclough C, Boyd K, Scroggs RA, Portner A, Slobod KS.

Viral Immunol. 2005;18(2):255-66. Review.

PMID:
16035938
2.

Gene-based vaccine approaches for respiratory syncytial virus.

Loomis RJ, Johnson PR.

Curr Top Microbiol Immunol. 2013;372:307-24. doi: 10.1007/978-3-642-38919-1_15. Review.

PMID:
24362696
3.

Sendai virus as a backbone for vaccines against RSV and other human paramyxoviruses.

Russell CJ, Hurwitz JL.

Expert Rev Vaccines. 2016;15(2):189-200. doi: 10.1586/14760584.2016.1114418. Epub 2015 Dec 9. Review.

4.

Advances in and the potential of vaccines for respiratory syncytial virus.

Jorquera PA, Oakley KE, Tripp RA.

Expert Rev Respir Med. 2013 Aug;7(4):411-27. doi: 10.1586/17476348.2013.814409. Review.

PMID:
23964629
5.

The non-structural proteins of RSV: targeting interferon antagonists for vaccine development.

Teng MN.

Infect Disord Drug Targets. 2012 Apr;12(2):129-37. Review.

PMID:
22335499
6.

Respiratory syncytial virus: reverse genetics and vaccine strategies.

Collins PL, Murphy BR.

Virology. 2002 May 10;296(2):204-11. Review. No abstract available.

7.

Subunit and virus-like particle vaccine approaches for respiratory syncytial virus.

Morrison TG, Walsh EE.

Curr Top Microbiol Immunol. 2013;372:285-306. doi: 10.1007/978-3-642-38919-1_14. Review.

PMID:
24362695
8.
9.

Immunopathology of RSV infection: prospects for developing vaccines without this complication.

van Drunen Littel-van den Hurk S, Mapletoft JW, Arsic N, Kovacs-Nolan J.

Rev Med Virol. 2007 Jan-Feb;17(1):5-34. Review.

PMID:
17004293
10.

The recent progress in RSV vaccine technology.

Fretzayas A, Papadopoulou A, Kotzia D, Moustaki M.

Recent Pat Antiinfect Drug Discov. 2012 Dec 1;7(3):237-41. Review.

PMID:
23072645
11.

Respiratory syncytial virus vaccine development.

Murata Y.

Clin Lab Med. 2009 Dec;29(4):725-39. doi: 10.1016/j.cll.2009.07.004. Review.

12.

Influenza and respiratory syncytial virus (RSV) vaccines for infants: safety, immunogenicity, and efficacy.

Beeler JA, Eichelberger MC.

Microb Pathog. 2013 Feb;55:9-15. doi: 10.1016/j.micpath.2012.11.013. Epub 2012 Dec 13. Review.

PMID:
23247146
13.

Current progress on development of respiratory syncytial virus vaccine.

Chang J.

BMB Rep. 2011 Apr;44(4):232-7. doi: DOI 10.5483/BMBRep.2011.44.4.232. Review.

14.

Respiratory syncytial virus, an ongoing medical dilemma: an expert commentary on respiratory syncytial virus prophylactic and therapeutic pharmaceuticals currently in clinical trials.

Broadbent L, Groves H, Shields MD, Power UF.

Influenza Other Respir Viruses. 2015 Jul;9(4):169-78. doi: 10.1111/irv.12313. Review.

15.

The role of dendritic cells in innate and adaptive immunity to respiratory syncytial virus, and implications for vaccine development.

Garg R, Shrivastava P, van Drunen Littel-van den Hurk S.

Expert Rev Vaccines. 2012 Dec;11(12):1441-57. doi: 10.1586/erv.12.117. Review.

PMID:
23252388
16.

Identifying targets in the hunt for effective respiratory syncytial virus interventions.

Tayyari F, Hegele RG.

Expert Rev Respir Med. 2012 Apr;6(2):215-22. doi: 10.1586/ers.12.8. Review.

PMID:
22455493
17.

Clinical experience with respiratory syncytial virus vaccines.

Piedra PA.

Pediatr Infect Dis J. 2003 Feb;22(2 Suppl):S94-9. Review.

PMID:
12671459
18.

Immunopathogenesis associated with formaldehyde-inactivated RSV vaccine in preclinical and clinical studies.

Muralidharan A, Li C, Wang L, Li X.

Expert Rev Vaccines. 2017 Apr;16(4):351-360. doi: 10.1080/14760584.2017.1260452. Epub 2016 Nov 21. Review.

PMID:
27841687
19.

Brief History and Characterization of Enhanced Respiratory Syncytial Virus Disease.

Acosta PL, Caballero MT, Polack FP.

Clin Vaccine Immunol. 2015 Dec 16;23(3):189-95. doi: 10.1128/CVI.00609-15. Review.

20.

Pharmacologic advances in the treatment and prevention of respiratory syncytial virus.

Empey KM, Peebles RS Jr, Kolls JK.

Clin Infect Dis. 2010 May 1;50(9):1258-67. doi: 10.1086/651603. Review.

Supplemental Content

Support Center